Section Review: Oncologic, Endocrine & Metabolic: Plant lectins in the prevention and control of tumour growth - future directions in cancer therapy?

References

• JOSHI SS, MESSBERGER LJ, HAO W: Differential sensitiv-ity of metastatic variant lymphoma cells to natural Immunity and effects of rIL-2 on their tumorigenicity in vivo. Proc. Assoc. Cancer Res. (1990) 28:275.
   Google Scholar
• US H, SHARON N: Lectins as molecules and as tools. Ann.Rev. Biochem. (1986) 55:35–37.
   PubMed Web of Science ®Google Scholar
• HEBERT E, MOSIGNY M: Galectin-3m RNA level dependson transformation phenotype in ras-transformed NM 3T3 cells. Biol. Cell (1994) 81:73–76.
   PubMed Web of Science ®Google Scholar
• KAICEJI Y, MAEHARA Y, TSUJITANI S, BABA H, OHNO S, WATANABE A, SUGIMACHI K: Helix pomatia agglutinin binding activity and lymph node metastasis in patients with gastric cancer. Semin. Surg. Oncol. (1994) 10:130–134.
   PubMed Web of Science ®Google Scholar
• KJONNIKSEN I, RYE PD, FODSTAND D: Helix pomatia agglutinin binding in human tumour cell lines: corre-lation with pulmonary metastasis in nude mice. Br. J. Cancer (1994) 69:1021–1024.
   PubMed Web of Science ®Google Scholar
• KNIBBS RN, MACCALLUM DK, LILLIE JH, GOLDSTEIN IJ:Wild type and cultured Ehrlich ascites tumour cells differ in tumorigenicity, lectin binding patterns and binding to basement membranes. Glycobiology (1994) 4:419–428.
   PubMed Web of Science ®Google Scholar
• PILLAI KR, REMANI P, KANNAN S, MATHEW A, SUJATHANK, VIJAYAKUMAR T, NAIR MK: Jack fruit lectin specificlycoconjugate expression during the progression of cervical intraepithelial neoplasia: a study on exfoliated cells. Diagn. Cytopathol. (1994) 10:342–346.
   PubMed Web of Science ®Google Scholar
• THOMAS M, NOGUCHI M, FONSECA L, KITAGAWA H,KINOSHITA K, MIYAZAKI I: Prognostic significance of Helix pomatia lectin and C-erb B-2 oncoprotein in human breast cancer. Br. J. Cancer (1993) 68:621–626.
   PubMed Web of Science ®Google Scholar
• DIXON A, SCHUMACHER U, PFULLER U, TAYLOR I: Is thebinding of mistletoe lectins land M a useful prognostic indicator in colorectal carcinoma? Eur. J. Surg. OncoL (1994) 20:648–652.
   Google Scholar
• OOKUMA Y, HACHISUGA T, IWASAKA T, SUGIMORI H:Assessment of lectin binding for prognosis in en-dometrial carcinoma. Pathology (1994) 26:225–229.
   PubMed Web of Science ®Google Scholar
• REMANI P, PILLAI KR, HASEENABEEVI VM, ANKATHIL R,BHATTATHIRI VN, NAIR MK, VIJAYKUMAR T: Lectin cyto-chemistry in exfoliative cytology of uterine cervix. Neoplasma (1994) 41:39–42.
   PubMedGoogle Scholar
• SCHUMACHER U, HIGGS D, LOIZIDOU M, PICKERING R,LEATHEM A, TAYLOR I: Helix pomatia agglutinin bind-ing is a useful prognostic indicator in colorectal carci-noma. Cancer (1994) 74:3104–3107.
   PubMed Web of Science ®Google Scholar
• LIENER IE, SHARON N, GOLDSTEIN IJ: The Lectins: Proper-ties, Functions and Application in Biology and Medicine. Academic Press, New York (1986).
   Google Scholar
• GABIUS HJ: Tumor lectinology: At the intersection of carbohydrate chemistry, biochemistry, cell biology and oncology. Angew. Chem. Int. Ed. (1988) 27:1267–1279.
   Web of Science ®Google Scholar
• MANN PL, SWARTZ CM, KELLEY RO: Cell surface oligos ac-charide modulation during differentiation. IL Mem-brane mobility of oligosaccharide lectin conjugates. Mech. Ageing Dev. (1987) 38:219–230.
   PubMed Web of Science ®Google Scholar
• MANN PL, SWARTZ CM, HOLMES DT: Cell surface oll-gosaccharide modulation during differentiation. N. Normal and transformed cell growth controL Mech. Ageing Dev. (1988) 44:17–33.
   Google Scholar
• HAJTO T, HOSTANSKA K, GABIUS HJ: Modulatory po-tency of the 13-galactoside specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res. (1989) 49:4803–4808.
   PubMed Web of Science ®Google Scholar
• HAJTO T, HOSTANSKA K, FRET K, PORDORF C, GABIUSH-J: Increased secretion of tumour necrosis factor-a, interleukln-1 and interleukin-6 by human mononu-clear cells exposed to P-galactoside specific lectin from clinically applied mistletoe extract. Cancer Res. (1990) 50:3322–3327.
   PubMed Web of Science ®Google Scholar
• GANGULY C, DAS S: Plant lectins as inhibitors of tumourgrowth and modulators of host immune response. Chemother. (1994) 40:272–278.
   PubMed Web of Science ®Google Scholar
• GANGULY C, DAS S: Response of peripheral blood lymphocytes and peritoneal macrophages of normal and tumour bearing mice to soyabean agglutinin. J. Basic Appl. Biomed. (1994) 2:41–43.
   Google Scholar
• NUMA K, TANI T, KODAMA M: Trial of anticancer immu-notherapy by extracorporeal circulation. Cancer Immu-not Immunother. (1990) 32:125–130.
   PubMed Web of Science ®Google Scholar
• OHNO S, TANAKA N, HIZUTA A, MIYAGI K, ORITA K: Lectin activated killer cells rapidly induced by poke-weed mitogen-conjugated beads and their in vivo anti-tumor effects. Intl. Immunopharmacol. (1994) 16:761–768.
   PubMed Web of Science ®Google Scholar
• WIMER BM: Characteristics of PHA-L4, the mitogenic isolectin of phytohemagglutimln as an ideal biological response modifier. Mol. Biother. (1990) 2:4–17.
   PubMedGoogle Scholar
• WIMER BM: Therapeutic activities of PHA-L4, the mito-genic isolectin of phytohemagglutinin. Mol. Biother. (1990) 2:74–90.
   PubMedGoogle Scholar
• WIMER BM: Potential therapeutic application of PHA-L4the mitogenic isolectin of phytohemagglutinin. .Mol. Biother. (1994) 2:196–200.
   Google Scholar
• MORGAN LR, KREMENTZ ET, FAN SW, FAN D: Adoptiveimrnunotherapy of advanced renal cell cancer using PHA-stimulated autologous lymphocytes. Anticancer Res. (1993) 13:1763–1767.
   PubMed Web of Science ®Google Scholar
• BOCCI V: Mistletoe (Vi scum album) lectins as cytokine Inducers and imrnunoadjuvant in tumour therapy. A review. J. Biol. Reg. Homeost. Agents (1993) 7:1–6.
   PubMed Web of Science ®Google Scholar
• HEINY BM, BEUTH J: Mistletoe extracts standardized for the gaLactoside specific lectin (ML-1) induce beta endor-phin release and inamunopotentiation in breast cancer. Anticancer Res, (1994) 14:1339–1342.
   PubMed Web of Science ®Google Scholar
• GABIUS HJ, GABIUS S, JOSHI SS, KOCH B, SCHROEDER M,MANZKE WM, WESTERHAUSEN M: From ill defined ex-tracts to the imruunomodulatory lectin: wffi there be a reason for oncological application of mistletoe? Planta Med. (1994) 60:2–7.
   Google Scholar
• GANGULY C, DAS S: Antitumour activity of two plantlectins. Ind. J. Cancer Chemother. (1991) 13:41–44.
   Google Scholar
• GANGULY C, DAS S: Lectins: good probes for cell surfacestudy as revealed by scanning electron microscopy. Cell Chrom. Res. (1992) 15:57–63.
   Google Scholar
• RAY C: Plant lectins and their possible role in malig-nancy. Ph.D. Thesis. Calcutta University (1992).
   Google Scholar
• KIM M, RAO MV, TWEARDY DJ, PRAKASH M, GALILI U, GORELIK E: Lectin-induced apoptosis of tumour cells. Glycobiology (1993) 3:447–453.
   PubMed Web of Science ®Google Scholar
• YU L, FERNIG DG, SMITH JA, MELTON JD, RHODES JM: Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin. Cancer Res. (1993) 53:4627–4632.
   PubMed Web of Science ®Google Scholar
• RYDER SD, PARKER N, ECCLESTONE D, HAQQANI MT, RHODES JM: Peanut lectin stimulates proliferation in colonic explants from patients with inflammatory bowel disease and colon polyps. Gastroenterology (1994) 106:117–124.
   PubMed Web of Science ®Google Scholar
• RYDER SD, SMITH JA, RHODES EG, PARKER N, RHODES JM: Proliferative responses of HT29 and Caco 2 human colorectal cancer cells to a panel of lectins. Gastroen-terology (1994) 106:85–93.
   PubMed Web of Science ®Google Scholar
• NAISBETT B, WOODEY J: The potential use of tomato lectin for oral drug delivery. 3. Bioadhesion in vivo. Int. J. Pharmaceut. (1995) 114:227–233.
   Web of Science ®Google Scholar
• JANSSEN O, SCHEFFLER A, KABELITZ D: In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to induction of programmed cell death (apoptosis). Arzneimitt. (1993) 43:1221–1227.
   Google Scholar
• BALZARINI J, SCHOLS D, NEYTS J, VAN DAMME E, PEU-MANS W, DE CLERCQ E: Alpha (1-3) and alpha (1-6) D-mannose specific plant lectins are markedly inhibi-tory to human immunodeficiency virus and cytomega-lovirus infections in vitro, Antimicrob. Agents Chemother. (1991) 35:410–416.
   PubMed Web of Science ®Google Scholar
• BALZARINI J, NEYTS J, SCHOLS D, HOSOYA M, VAN DAMME E, PEUMANS W, DE CLERCQ E: The mannose specific plant lectins from cymbidium hybrid and Ept-pactis belleborine and the (N-acetylglucosamine) n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro. Antiviral Res. (1992) 18:191–207.
   PubMed Web of Science ®Google Scholar
• DE CLERCQ E: New perspectives for the chemotherapy and chemoprophylaxis of AIDS. Verb. K. Acad. Gene-ceskd. Belg. (1992) 54:57–88.
   PubMedGoogle Scholar
• YANG D, HARAGUCHI Y, IWAI H, HANDA A, SHIMIZU N, HOSHINO H: Inhibition of adsorption of human T-cell leukemia virus type 1 by a plant lectin, wheat germ agglutinin. Int.J. Cancer (1994) 56:100–105.
   PubMed Web of Science ®Google Scholar
• PULVERER G, BEUTH J, KO HL: Importance of lectins for the prevention of bacterial infection and cancer metas-tases. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dig. (1994) 281:324–333.
   Web of Science ®Google Scholar
• LIENER IE: From soyabeans to lectins: a trail of research revisited. Carbohydrate Res. (1991) 213:1–5.
   PubMed Web of Science ®Google Scholar
• MOKHTAR NM, EL AASER AA, EL BOLKAINY MN: Effect of soyabean feeding on experimental carcinogenesis. M. Carcinogenicity of nitrite and dibutylamine in mice: a histopathological study. Eur.J. Cancer Clin. OncoL (1988) 24:403–411.
   PubMed Web of Science ®Google Scholar
• FITZSIMONS JT, ORSON NV, EL AASER AA: Effects of soyabean and ascorbic acid on experimental carcino-genesis. Comp. Biochem. Physiol. (1989) 93:285–290.
   Google Scholar
• DAS S, MUKHOPADHYAY P, DAS GUPTA J: Prevention and control of murine leukaemia and lymphoma by soyabean supplemented diet. J. Physiol. Applied Sci. (1992) 46:178–185.
   Google Scholar
• MUKHOPADI-IYAY P, DAS GUPTA J, SANYAL U, DAS S:Influence of dietary restriction and soyabean supple-mentation on the growth of a murine lymphoma and host immune function. Cancer Lett. (1994) 78:151–157.
   PubMed Web of Science ®Google Scholar
• PRYME IF, PUSZTAI AJ, BARDOCZ S: A diet containinglectin phytohaemagglutinin slows down the prolifera-tion of Krebs II cell tumours in mice. Cancer Lett. (1994) 76:133–137.
   PubMed Web of Science ®Google Scholar